We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Top Buys
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
HA
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| 1 | Financials | 16.98% |
| 2 | Industrials | 15.81% |
| 3 | Technology | 13.65% |
| 4 | Consumer Discretionary | 11.93% |
| 5 | Healthcare | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBI
26
Trueblue
TBI
$247M
| $9.34M | 0.86% |
352,325
+24,625
| +8% | +$657K |
|
27
TriNet
TNET
$2.75B
| $9.24M | 0.86% |
282,371
+139,064
| +97% | +$4.25M |
|
28
Worthington Enterprises
WOR
$2.76B
| $9.21M | 0.85% |
297,460
+5,017
| +2% | +$135K |
|
|
RDUS
29
DELISTED
Radius Recycling
RDUS
| $9.02M | 0.83% |
357,911
-103,126
| -22% | -$2.04M |
|
|
LQ
30
DELISTED
La Quinta Holdings Inc.
LQ
| $8.96M | 0.83% |
606,416
+21,380
| +4% | +$302K |
|
31
Allegiant Air
ALGT
$2.74B
| $8.91M | 0.82% |
65,734
+2,221
| +3% | +$325K |
|
32
Emergent Biosolutions
EBS
$393M
| $8.91M | 0.82% |
262,741
+5,075
| +2% | +$157K |
|
|
MASI
33
DELISTED
Masimo
MASI
| $8.79M | 0.81% |
96,444
-50,217
| -34% | -$4.61M |
|
|
AAWW
34
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $8.73M | 0.81% |
167,322
+126,538
| +310% | +$6.67M |
|
35
Hilltop Holdings
HTH
$2.27B
| $8.67M | 0.8% |
330,837
+6,133
| +2% | +$163K |
|
36
REX American Resources
REX
$1.55B
| $8.56M | 0.79% |
532,056
-21,954
| -4% | -$348K |
|
37
Usana Health Sciences
USNA
$402M
| $8.51M | 0.79% |
132,801
-4,628
| -3% | -$285K |
|
38
Stepan Co
SCL
$1.33B
| $8.48M | 0.78% |
97,307
-9,015
| -8% | -$758K |
|
39
Insight Enterprises
NSIT
$3.48B
| $8.33M | 0.77% |
208,330
-21,844
| -9% | -$923K |
|
40
Delek US
DK
$3.84B
| $8.29M | 0.77% |
313,700
+81,140
| +35% | +$2M |
|
|
WDR
41
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $8.27M | 0.77% |
437,909
+42,542
| +11% | +$747K |
|
42
ArcBest
ARCB
$3.53B
| $8.26M | 0.76% |
401,071
+14,287
| +4% | +$310K |
|
|
HRC
43
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.24M | 0.76% |
103,480
+1,464
| +1% | +$111K |
|
44
UMB Financial
UMBF
$11.1B
| $8.22M | 0.76% |
109,759
+2,716
| +3% | +$199K |
|
|
EGRX
45
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $8.16M | 0.76% |
+103,444
| New | +$8.46M |
|
|
LM
46
DELISTED
Legg Mason, Inc.
LM
| $7.99M | 0.74% |
+209,463
| New | +$7.93M |
|
|
DFT
47
DELISTED
DuPont Fabros Technology Inc.
DFT
| $7.88M | 0.73% |
128,781
-27,966
| -18% | -$1.54M |
|
|
TECD
48
DELISTED
Tech Data Corp
TECD
| $7.83M | 0.72% |
77,532
+40,864
| +111% | +$3.93M |
|
49
Titan International
TWI
$494M
| $7.83M | 0.72% |
651,955
-134,119
| -17% | -$1.45M |
|
50
SiriusPoint
SPNT
$2.94B
| $7.79M | 0.72% |
560,457
+124,409
| +29% | +$1.58M |
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.